Kristina Shaffer, MD
Dermatology · Eagan, MNNPI 1730298910
Payments from drug & device makers
Across 485 payments — averaging $1108.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$534K
- Lumenis BE Inc$2K
- Musculoskeletal Transplant Foundation Inc.$799
- Solta Medical, A Division Of Bausch Health US, LLC$265
- Regeneron Healthcare Solutions, Inc.$95
- Johnson & Johnson$34
- plus $115 from 6 others
What the payments were for
- Consulting fees$8,9702%
- Speaking & faculty fees$459,12585%
- Travel & lodging$56,92511%
- Food & beverage$12,6732%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 465 | $534,470 |
| Lumenis BE Inc | 1 | $1,944 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $799 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $265 |
| Regeneron Healthcare Solutions, Inc. | 5 | $95 |
| Johnson & Johnson | 2 | $34 |
| Amgen | 2 | $30 |
| Sanofi | 1 | $23 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| UCB, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Smith+Nephew | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$263,769
- BOTOX COSMETIC$8,733
- KYBELLA$1,950
- M22$1,944
How this compares
$537,723 in reported general payments places this provider in the 95th percentile of 273 dermatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 13 | $87,669 |
| Dupixent PenDupilumab | 12 | $44,601 |
| Metronidazole | 46 | $3,847 |
| Acitretin | 14 | $3,633 |
| Clobetasol Propionate | 97 | $3,266 |
| Fluorouracil | 34 | $2,781 |
| Azelaic Acid | 19 | $2,127 |
| Ketoconazole | 103 | $2,113 |
| Sulfacetamide Sodium | 17 | $1,563 |
| Fluocinolone Acetonide | 25 | $1,244 |
| Tretinoin | 14 | $1,145 |
| Clindamycin Phosphate | 34 | $1,059 |
| Desonide | 24 | $1,035 |
| Tacrolimus | 12 | $841 |
| ValacyclovirValacyclovir Hcl | 74 | $840 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Eagan
- Steven KempersFridley$5.1M
- Maria HordinskyMinneapolis$2.1M
- Margareth Pierre-LouisMinneapolis$456K
- Afsaneh AlaviRochester$440K
- Noah GoldfarbMinneapolis$359K
- Michael CamilleriRochester$297K
- Megha TollefsonRochester$243K
- Paul BigliardiMinneapolis$237K
- David PearsonMinneapolis$164K
- Kimberly BohjanenMinneapolis$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.